Cardiorenal Syndrome Revisited

Area of Science:

• Cardiology
• Nephrology
• Pathophysiology

Background:

• Cardiorenal syndromes are classified into 5 subtypes, but this descriptive approach lacks pathophysiological insight and clinical impact.
• Existing classifications do not fully explain the complex interplay between cardiac and renal dysfunction.
• Recent research points to shared pathophysiological pathways underlying cardiorenal syndromes.

Purpose of the Study:

• To propose fibrosis as a unifying pathogenic mechanism in cardiorenal syndromes.
• To shift focus from descriptive classification to a mechanistic understanding of cardiorenal interactions.
• To identify fibrosis as a potential therapeutic target for cardiorenal conditions.

Main Methods:

• Review of current scientific literature on cardiorenal syndromes and fibrosis.
• Analysis of common pathophysiological pathways linking cardiac and renal diseases.
• Conceptualization of fibrosis as a central mediator in the cardiorenal syndrome continuum.

Main Results:

• Fibrosis is identified as a common consequence of inflammation and oxidative stress in conditions like aging, hypertension, and diabetes.
• Interstitial fibrosis is a prevalent feature in both heart failure and chronic kidney disease.
• Fibrosis is proposed as a potential primary driver, not just a marker, of cardiorenal pathophysiology.

Conclusions:

• Fibrosis may serve as a central pathogenic mechanism across various cardiorenal syndromes.
• Targeting fibrosis could offer a novel therapeutic strategy for cardiorenal conditions.
• Developing antifibrotic agents may revolutionize the prevention and treatment of cardiorenal syndrome.